Jennifer McMahon

Jennifer McMahon

Director/Board Member at Biosensia Ltd.

Finance
Consumer Services
Health Technology

Profile

Jennifer McMahon is a Partner at Seroba.
She graduated from UCD with an honours degree in Pharmacology in 2010.
Jennifer then entered a Master’s degree programme in Biotechnology and Business to further her interest in the interface of biomedical science with commercialisation.
Having placed first in her Master’s degree in 2011, Jennifer then joined Seroba’s Investment Team as an Investment Analyst, progressing to Partner in 2022.
In 2019, Jennifer joined the Advisory Board for the European healthcare Businesswomen’s Association.
She is Chair of Level20 Europe and was a founder member of the Ireland Chapter of Level20.
She guest lectures on venture capital at University College Dublin, Trinity College Dublin and the Royal College of Surgeons in Ireland.
She is also in high demand as a speaker at Investor/Entrepreneur life science partnering conferences across Europe.
Jennifer sits on the boards of Endotronix and Palliare, is a Board Observer to Shorla Pharma and was previously on the Board of Biosensia prior to its merger with Kypha Diagnostics.

Jennifer McMahon active positions

CompaniesPositionStart
Private Equity Analyst 2010-12-31
Director/Board Member -
Director/Board Member -
All active positions of Jennifer McMahon

Former positions of Jennifer McMahon

CompaniesPositionEnd
Private Equity Analyst -
See the detail of Jennifer McMahon's experience

Training of Jennifer McMahon

University College Dublin Undergraduate Degree
UCD Michael Smurfit Graduate School of Business Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jennifer McMahon's experience

Connections

89

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies4

Finance

Finance

Health Technology

Technology Services

See company connections
  1. Stock Market
  2. Insiders
  3. Jennifer McMahon